| Primary |
| Product Used For Unknown Indication |
19.0% |
| Upper Respiratory Tract Infection |
16.7% |
| Bronchitis |
7.1% |
| Infection Prophylaxis |
7.1% |
| Tonsillitis |
7.1% |
| Endocarditis |
4.8% |
| Pain |
4.8% |
| Tooth Abscess |
4.8% |
| Anxiety |
2.4% |
| Asthma |
2.4% |
| Bacterial Infection |
2.4% |
| Beta Haemolytic Streptococcal Infection |
2.4% |
| Blood Cholesterol Increased |
2.4% |
| Hormone Level Abnormal |
2.4% |
| Hypertension |
2.4% |
| Pharyngitis |
2.4% |
| Pharyngitis Streptococcal |
2.4% |
| Syphilis |
2.4% |
| Tonsillitis Streptococcal |
2.4% |
| Uterine Contractions During Pregnancy |
2.4% |
|
| Drug Hypersensitivity |
68.1% |
| No Adverse Event |
6.9% |
| Hypersensitivity |
3.5% |
| Toxic Epidermal Necrolysis |
2.8% |
| Vomiting |
2.1% |
| Agranulocytosis |
1.4% |
| Infusion Site Irritation |
1.4% |
| Loss Of Consciousness |
1.4% |
| Maternal Exposure During Pregnancy |
1.4% |
| Panniculitis |
1.4% |
| Pruritus |
1.4% |
| Rash |
1.4% |
| Sepsis |
1.4% |
| Swelling |
1.4% |
| Abdominal Discomfort |
0.7% |
| Blood Potassium Decreased |
0.7% |
| Bone Density Abnormal |
0.7% |
| Cardiac Arrest |
0.7% |
| Death |
0.7% |
| Diabetes Mellitus |
0.7% |
|
| Secondary |
| Erysipelas |
19.1% |
| Drug Use For Unknown Indication |
17.0% |
| Arterial Disorder |
6.4% |
| Hypertension |
6.4% |
| Iron Deficiency |
6.4% |
| Pneumonia |
6.4% |
| Prophylaxis |
6.4% |
| Tonsillitis |
6.4% |
| Asthma |
4.3% |
| Product Used For Unknown Indication |
4.3% |
| Abscess |
2.1% |
| Anxiety |
2.1% |
| Emphysema |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Heart Valve Replacement |
2.1% |
| Pain |
2.1% |
| Sepsis |
2.1% |
| Wisdom Teeth Removal |
2.1% |
|
| Drug Hypersensitivity |
46.7% |
| Dyspnoea |
6.7% |
| Renal Failure Acute |
6.7% |
| Apnoea |
3.3% |
| Cardio-respiratory Arrest |
3.3% |
| Familial Risk Factor |
3.3% |
| Hyperkalaemia |
3.3% |
| Hypersensitivity |
3.3% |
| Hypotension |
3.3% |
| Infusion Site Pain |
3.3% |
| Maternal Exposure During Pregnancy |
3.3% |
| Rash |
3.3% |
| Septic Shock |
3.3% |
| Urinary Tract Infection |
3.3% |
| Vomiting Projectile |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
16.7% |
| Multiple Myeloma |
7.9% |
| Nausea |
7.9% |
| Anxiety |
7.1% |
| Pain |
7.1% |
| Hiv Infection |
6.3% |
| Sepsis |
4.8% |
| Depression |
4.0% |
| Multiple Sclerosis |
4.0% |
| Osteoarthritis |
4.0% |
| Pneumonia |
4.0% |
| Antibiotic Therapy |
3.2% |
| Cellulitis |
3.2% |
| Congestive Cardiomyopathy |
3.2% |
| Musculoskeletal Chest Pain |
3.2% |
| Prophylaxis |
3.2% |
| Vomiting |
3.2% |
| Dyspepsia |
2.4% |
| Endocarditis |
2.4% |
| Infection Prophylaxis |
2.4% |
|
| Acute Respiratory Distress Syndrome |
14.8% |
| Pneumocystis Jiroveci Pneumonia |
7.4% |
| Pneumonia |
7.4% |
| Sensory Disturbance |
7.4% |
| Vesicoureteric Reflux |
7.4% |
| Anisocytosis |
3.7% |
| Aplastic Anaemia |
3.7% |
| Aspartate Aminotransferase Increased |
3.7% |
| C-reactive Protein Increased |
3.7% |
| Cardiac Failure |
3.7% |
| Chest Pain |
3.7% |
| Disseminated Intravascular Coagulation |
3.7% |
| Dizziness |
3.7% |
| Drug Ineffective |
3.7% |
| Drug Screen False Positive |
3.7% |
| Flank Pain |
3.7% |
| Gastrooesophageal Reflux Disease |
3.7% |
| Haemolytic Anaemia |
3.7% |
| Hospitalisation |
3.7% |
| Hyperviscosity Syndrome |
3.7% |
|
